Abstract
As part of the preclinical safety evaluation process, an investigational macrolide antibiotic, LY281389, was examined for autonomic activity in isolated smooth and cardiac muscle preparations and for cardiovascular effects by intravenous infusion in anesthetized beagles. Concentration-dependent antagonism of acetylcholine and angiotensin I (guinea pig ileum), norepinephrine (rat vas deferens), and isoproterenol (guinea pig atria) was observed at LY281389 concentrations of greater than or equal to 10(-5) M. At LY281389 concentrations of greater than or equal to 10(-4) M, the response of the guinea pig ileum to electrical stimulation was also inhibited approximately 65 to 100%, indicative of potential anticholinergic or alpha-adrenergic activity. In anesthetized dogs, the predominant effect of LY281389 was an increase in heart rate at doses of greater than or equal to 200 micrograms/kg of body weight. LY281389 also produced slight increases in mean arterial pressure and shortening of the P-R interval of the electrocardiogram. In summary, LY281389 possesses nonselective receptor antagonist activity in vitro and produces cardiovascular stimulation in anesthetized dogs. These results indicate that, in addition to potent antimicrobial activity, the macrolide antibiotic LY281389 may exert unexpected actions on cardiovascular function.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arnold J. M., McDevitt D. G. Contribution of the vagus to the haemodynamic responses following intravenous boluses of isoprenaline. Br J Clin Pharmacol. 1983 Apr;15(4):423–429. doi: 10.1111/j.1365-2125.1983.tb01525.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cohen L. S., Wechsler A. S., Mitchell J. H., Glick G. Depression of cardiac function by streptomycin and other antimicrobial agents. Am J Cardiol. 1970 Nov;26(5):505–511. doi: 10.1016/0002-9149(70)90708-3. [DOI] [PubMed] [Google Scholar]
- Freedman R. A., Anderson K. P., Green L. S., Mason J. W. Effect of erythromycin on ventricular arrhythmias and ventricular repolarization in idiopathic long QT syndrome. Am J Cardiol. 1987 Jan 1;59(1):168–169. doi: 10.1016/s0002-9149(87)80096-6. [DOI] [PubMed] [Google Scholar]
- Goldstein R. E., Karsh R. B., Smith E. R., Orlando M., Norman D., Farnham G., Redwood D. R., Epstein S. E. Influence of atropine and of vagally mediated bradycardia on the occurrence of ventricular arrhythmias following acute coronary occlusion in closed-chest dogs. Circulation. 1973 Jun;47(6):1180–1190. doi: 10.1161/01.cir.47.6.1180. [DOI] [PubMed] [Google Scholar]
- Kirst H. A., Wind J. A., Leeds J. P., Willard K. E., Debono M., Bonjouklian R., Greene J. M., Sullivan K. A., Paschal J. W., Deeter J. B. Synthesis and structure-activity relationships of new 9-N-alkyl derivatives of 9(S)-erythromycylamine. J Med Chem. 1990 Nov;33(11):3086–3094. doi: 10.1021/jm00173a028. [DOI] [PubMed] [Google Scholar]
- Kuriaki K., Miki H., Sejima Y., Shibata M., Ida H. [New antibiotics, Josamycin. V. Studies on toxicity of Josamycin]. Jpn J Antibiot. 1969 Jun;22(3):219–225. [PubMed] [Google Scholar]
- McComb J. M., Campbell N. P., Cleland J. Recurrent ventricular tachycardia associated with QT prolongation after mitral valve replacement and its association with intravenous administration of erythromycin. Am J Cardiol. 1984 Oct 1;54(7):922–923. doi: 10.1016/s0002-9149(84)80237-4. [DOI] [PubMed] [Google Scholar]
- Tamargo J., De Miguel B., Tejerina M. T. A comparison of josamycin with macrolides and related antibiotics on isolated rat atria. Eur J Pharmacol. 1982 Jun 4;80(4):285–293. doi: 10.1016/0014-2999(82)90073-5. [DOI] [PubMed] [Google Scholar]